Zydus Lifesciences receives USFDA approval for generic Leuprolide Acetate injection, used in advanced prostatic cancer ...
AbbVie (NYSE: ABBV) announced today that a new 6-month 45mg LUPRON DEPOT® (leuprolide acetate for extended-release injectable suspension) strength has received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback